secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2024-06-05T23:59:59+00:00
Accession:  0001654954-24-007369
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata regains Nasdaq minimum bid price compliance; delisting risk resolved
----------------------------------------------------------------------------

- Received Nasdaq notice on June 4, 2024 that company is in compliance with $1.00 minimum bid price requirement.
- Previously failed to comply in Nov 2023 and received a 180-day extension through Nov 11, 2024.
- Compliance regained ahead of extension deadline; matter closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000165495424007369/0001654954-24-007369-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000165495424007369/drma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-007369

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer